Faculty Profile: Matthew Jankowich, M.D.

Matthew Jankowich
Matthew Jankowich, M.D.
Assistant Professor of Medicine
Medicine
Work: +1 401-273-7100
Dr. Jankowich is conducting clinical and epidemiologic research focused on the interactions between lung function and systemic vascular disease. Dr. Jankowich's work is focused on improving understanding of the factors associated with increased cardiovascular risk in the setting of lung function impairment. He also conducts research on pulmonary hypertension and he has studied the advanced lung disease syndrome combined pulmonary fibrosis and emphysema.

Biography

Matthew D. Jankowich, MD is an Assistant Professor of Medicine at the Alpert Medical School of Brown University and is a staff physician at the Providence VA Medical Center. Dr. Jankowich is a graduate of Dartmouth College and of the Ohio State University College of Medicine. He did his internship in internal medicine at the Yale-New Haven Hospital in New Haven, CT and completed his residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, MA. He subsequently completed his fellowship in Pulmonary and Critical Care Medicine at Brown University, performing research in the Vascular Research Laboratory at the Providence VA Medical Center. After graduating from his fellowship, he took a staff position at the Providence VA Medical Center, where he is co-director of the Pulmonary Hypertension clinic.

Dr. Jankowich has interests in clinical pulmonary and critical care medicine as well as teaching and research. His clinical interests include lung cancer, pulmonary hypertension, and the use of ultrasound in pulmonary medicine, including endobronchial ultrasound. He is a course director for the Pulmonary physiology and pathophysiology section of BIOL 3662 IMS III. His research interests include pulmonary hypertension, the advanced lung disease phenotype combined pulmonary fibrosis and emphysema, and the study of the interactions between lung disease and systemic and pulmonary vascular disease. Dr. Jankowich conducts his research at the Vascular Research Laboratory.

Grants and Awards

2012: Dean's Excellence in Teaching Award, Warren Alpert Medical School of Brown University, BIOL 3662: IMS III: Pulmonary.

Affiliations

American Thoracic Society
American College of Chest Physicians
American Association of Bronchology and Interventional Pulmonology
RI Thoracic Society

Funded Research

2010-2011 Department of Medicine, Chairman's Developmental Research Grant. "The effect of pulmonary rehabilitation on systemic vascular function in COPD." $25,000/year x 1-2 years, awarded 11/2010.

2012-2013 The Rhode Island Foundation. "Effect of cardiovascular risk reduction on systemic vascular function in diabetics with COPD." Grant number 20113648. $13,790 x 1 year.

2012-2016 Site investigator, CSP#574 "Extended Steroid in CAP(e) (ESCAPe): A Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of Methylprednisolone in Hospitalized Veterans with Severe Community-Acquired Pneumonia". VA Cooperative Study. Local site budgetary support: $24,514 (in 2012); $58,930 (2013-2016).

Teaching Experience

Dr. Jankowich is the course co-director for Pulmonary Physiology and Pathophysiology in BIOL 3662 IMS III.
Dr. Jankowich is course leader for the IM-331: Pulmonary Diseases clinical elective at the Providence VA Medical Center.

Courses Taught

  • Pulmonary Physiology and Pathophysiology (BIOL 3663)

Selected Publications

  • Maron BA, Choudhary G, Khan U, Jankowich MD, McChesney H, Ferrazzani SJ, Gaddam S, Sharma S, Opotowsky AR, Bhatt DL, Rocco TP, Aragam JR. The clinical profile and under-diagnosis of pulmonary hypertension in U.S. veteran patients. Circ Heart Fail 2013 Jun 27. [Epub ahead of print]. PMID: 23811965. (2013)
  • Jankowich MD. Idiopathic pulmonary fibrosis. In: First Consult. Editor-in-Chief Margaret T. Hessen, M.D., F.A.C.P.. Elsevier: Electronically published, February, 2013. (Electronic Publication) (2013)
  • Choudhary G, Jankowich M, Wu W-C. Prevalence and clinical characteristics associated with pulmonary hypertension in African-Americans. PLoS ONE 2013; 8(12): e84264. doi: 10.1371/journal.pone.0084264. (2013)
  • Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome—a review. Chest 2012; 141(1): 222-231. PMID: 22215830. (2012)
  • Jankowich MD, , Martin DW, Choudhary G. Cor Pulmonale. In: Ferri's Clinical Adviser 2013. Edited by Fred F. Ferri, M.D., F.A.C.P. Elsevier Mosby: Philadelphia 2012. (2012)
  • Jankowich MD, Ferri FF. Pulmonary edema. In: Ferri's Clinical Adviser 2013. Edited by Fred F. Ferri, M.D., F.A.C.P. Elsevier Mosby: Philadelphia 2012. (2012)
  • Jankowich MD, Ferri FF. Pulmonary embolism. In: Ferri's Clinical Adviser 2013. Edited by Fred F. Ferri, M.D., F.A.C.P. Elsevier Mosby: Philadelphia 2012. (2012)
  • Jankowich MD, Martin DW, Choudhary G. Pulmonary hypertension. In: Ferri's Clinical Adviser 2013. Edited by Fred F. Ferri, M.D., F.A.C.P. Elsevier Mosby: Philadelphia 2012. (2012)
  • Jankowich M, Choudhary G, Taveira TH, Wu WC. Age-, race-, and gender-specific prevalence of diabetes among smokers. Diabetes Res Clin Pract 2011; 93: 101-105. (2011)
  • Jankowich M. Thoracic malignancies. In: Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences, first edition. Edited by Linda Nici, M.D. and Richard ZuWallack, M.D. Humana Press, Springer; New York 2012. (2011)
  • Jankowich M, Taveira T, Wu W-C. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III. Am J Hypertens 2010; 23: 614-619. (2010)
  • Lu Q*, Jankowich M*, Newton J, Harrington EO, Rounds S. Alterations in molecular chaperones and EIF2α during lung endothelial cell apoptosis. Amer J Physiol: Lung Cellular and Molecular Physiology 2010; 298: L501-L508. (*Equal contributions). (2010)
  • Rounds S and Jankowich MD. The Lung in Health and Disease. In: Andreoli and Carpenter's Cecil Essentials of Medicine, eighth edition. Edited by Thomas E. Andreoli et al. Saunders Elsevier. Philadelphia, 2010. (2010)
  • Jankowich MD. Obstructive Lung Diseases. In: Andreoli and Carpenter's Cecil Essentials of Medicine, eighth edition. Edited by Thomas E. Andreoli et al. Saunders Elsevier. Philadelphia, 2010. (2010)
  • Aliotta JA and Jankowich MD. Interstitial Lung Disease. In: Andreoli and Carpenter's Cecil Essentials of Medicine, eighth edition. Edited by Thomas E. Andreoli et al. Saunders Elsevier. Philadelphia, 2010. (2010)
  • Rounds S and Jankowich MD. Disorders of Respiratory Control. In: Andreoli and Carpenter's Cecil Essentials of Medicine, eighth edition. Edited by Thomas E. Andreoli et al. Saunders Elsevier. Philadelphia, 2010. (2010)
  • Aliotta JA and Jankowich MD. Neoplastic Disorders of the Lung. In: Andreoli and Carpenter's Cecil Essentials of Medicine, eighth edition. Edited by Thomas E. Andreoli et al. Saunders Elsevier. Philadelphia, 2010. (2010)
  • Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema results in altered physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010. July 8. Epublished before print. PMID 20614219. (2010)
  • Jankowich M, Choudhary G, and Rounds S. Hypoxia and the Pulmonary Endothelium. In: The Pulmonary Endothelium: Function in Health and Disease. Edited by Sharon Rounds and Norbert Voelkel. John Wiley and Sons, LTD., 2009. (2009)
  • Jankowich M, Polsky M., Klein M, and Rounds S. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75: 411-417. (2008)
  • Jankowich M, Sameed YA, and Abu-Hijleh, M. A 21-year-old man with fever and sore throat rapidly progressive to hemoptysis and respiratory failure. Diagnosis: Lemierre syndrome with Fusobacterium necrophorum sepsis. Chest 2007; 132: 1706-1709. (2007)
  • Lu Q, Harrington EO, Newton J, Jankowich M, and Round S. Inhibition of ICMT induces endothelial cell apoptosis through GRP94. Am J Respir Cell Mol Biol 2007; 37(1): 20-30. (2007)
  • Jankowich MD, Wahidi MM, Feller-Kopman D, and Ernst A. Pulmonary alveolar proteinosis diagnosed in pregnancy and managed with whole-lung lavage. J Bronchol 2006; 13: 204-206. (2006)